Although more attention has been focused on the health needs of the developing world through the activities of the Bill and Melinda Gates Foundation and other similar organizations, many challenges remain ahead. To be successful in this endeavor requires the collaboration of innovative biotechnology companies with therapeutic and diagnostic development expertise, academic researchers to elucidate novel biochemical and molecular pathways within disease states, and the financial support to bring new treatments to affected populations.

This BioBreakfast program will feature a panel of academic experts from the University of Maryland School of Medicine whose dedicated research efforts are showing promise in many parts of the world. Joining these researchers are business executives who will discuss their innovative programs and technologies aimed at treating some of the most devastating diseases in the developing world today. The MdBio Division of the Tech Council of Maryland invites you to register now to learn about these important efforts.

Our panelists include:

Joseph O'Neill, MD, MS, MPH (Moderator)
Director, University of Maryland Global Health Initiatives
Visiting Professor, University of Maryland School of Medicine

Eddy Agbo, DVM, MS, PhD
Chairman and CEO
Fyodor Biotechnologies, Inc.

Gary Horwith, MD
Chief Medical Officer
Sequella, Inc.

Philippe Jacon
President
Becton Dickinson Diagnostic Systems

Priya Mehta
Director, Global Health Markets
BIO Ventures for Global Health

Professor Christopher Plowe, MD, MPH
Chief of Malaria Section, Center for Vaccine Development
University of Maryland School of Medicine

Professor Richard Zhao, MS, PhD
Associate Professor of Pathology and Head, Division of Molecular Pathology
University of Maryland School of Medicine

Registration and networking from 7:30 - 8:15am; the program will begin at 8:30am